Discovery of genetic glitches in gene formatting (RNU4-2 mutations) discloses a new cause for blindness, solving retinal ...
About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...
A blind sailor is aiming for the Paralympics in Brisbane in 2032, after winning medals in the World Sailing Inclusion ...
In patients with retinitis pigmentosa (RP), crucial cells in the retina known as rods and cones die over time; night ...
A special art show at Bryn Mawr Rehab Hospital aims to raise community awareness about cognitive and physical disabilities.
Parents and students at the Arizona State Schools for the Deaf and Blind (ASDB) Tucson campus continue to speak out against ...
People should do these checks often, whether they are just starting to drive or have been behind the wheel for years ...
A microchip smaller than a grain developed by scientists across 17 hospitals is restoring central vision to people who were ...
MT. HOOD, Ore. (KPTV) - A program for blind and visually impaired athletes kicked-off Wednesday at Mt. Hood Meadows, breaking ...
Drivers across the UK have been warned not to get in the car until they have completed certain safety checks. And it's ...
Nanoscope has received a new patent ( US Patent No. 12459977) from the US Patent and Trademark Office (USPTO) for the company’s Multi-Characteristic Opsin (MCO) technology platform as a novel and ...